NEAR Partners with Cosmose AI to Develop Crypto Payment Solution

NEAR Foundation, a pioneer in Web3 technologies, has made a strategic investment in Cosmose AI, valuing the firm at $500 million. 

New Alliance Between NEAR and Cosmose AI

Cosmose will use the additional funding for further development within the Web3 ecosystem, resulting in a better shopping experience for customers and more revenues for retailers.

Furthermore, Cosmose Media and KaiKai, two Cosmose AI products, will push Web3-driven advancements through this collaboration with the NEAR Foundation. 

What is Cosmose AI?

Cosmose AI is an international infrastructure that forecasts and impacts how consumers purchase offline. The firm intends to utilize Web3 concepts and enhance the AI-driven retail ecosystem with the latest funding.

Cosmose AI, founded in 2014, links the finest of both online and offline experiences to offer an effortless visit for customers and enhance sales for shops. It works with a number of the world’s most well-known brands, like LVMH, Richemont, L’Oréal, and Estée Lauder. 

Cosmose AI Receives Support from NEAR

Miron Mironiuk, Founder and CEO of Cosmose AI, commented on the collaboration, saying:

“We are grateful for the ongoing support from NEAR Foundation and are excited about what’s to come. NEAR is the most secure, scalable, and sustainable blockchain protocol.”

NEAR Protocol is among the most sophisticated blockchain technology available right now, providing the quickest and most cost-effective data storage and administration solutions.

It established a $800 million awards fund in 2021, with distinct amounts designated for specific objectives.

NEAR Expands Presence in AI

“We are excited to be supporting Cosmose as it continues to scale rapidly and to create new ways for retailers to offer customers the best and most seamless offline and online shopping experiences,” expressed Marieke Flament, CEO of the NEAR Foundation.

As artificial intelligence (AI) continues to push the frontiers of technological advancement into businesses, the benefit to the larger community from emerging new solutions appears to be quite promising. 

It is important to mention here that ClinTex, an Estonian healthcare technology business, is attempting to increase its focus on the integration of AI into the clinical trial process.